“Good protection for many (with one shot) is better than excellent protection for a few. 2,000 people a day die because they can’t get the first shot # covid19 – not because they can’t get a second,” Adams wrote a
On Twitter. In another tweet, Adams wrote, “Push all the doses NOW and lean into production!”
Adams included a link to an article published Monday by The Washington Post in which Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and chief adviser to the Biden administration, said the United States should stay with a two-dose vaccine regimen. Pfizer / BioNTech and Moderna.
Fauci told the newspaper that there were “risks on both sides” of switching to a single dose or staying with both.
“It simply came to our notice then [two shots] is that what you should do … and then we say “Oops, we changed our minds”? “I think it would be a messaging challenge, to say the least,” said the top disease expert.
On Tuesday, Adams tried to clarify his comments.
“I do not say it is [100 emoji] the right path. I say there is enough data / evidence to suggest that it is not [100 emoji] the wrong way – and with 2,000 (unvaccinated) people dying a day, it’s worth giving states the flexibility to try, “he said.
posted on Twitter.
Against the low background of the vaccine, a number of experts argued that the second dose was delayed in favor of receiving more people, and some research suggested a high degree of temporary protection from a single dose. However, the US Food and Drug Administration and top US officials have pushed for this, saying it is unclear how long that protection will last and arguing the need to comply with evidence from clinical trials.
In a discussion of vaccines on Monday at a meeting of the US Centers for Disease Control and Prevention Advisory Committee, experts said two doses better protect people against coronavirus than a single dose. US health officials are worried that the spread of several infectious variants could hinder the country in its fight to control the pandemic.
Although the Pfizer and Moderna Covid-19 vaccines were tested as a two-dose regimen, the UK switched to delaying the second dose to get more first doses in more people faster.
Over the weekend, the FDA approved Johnson & Johnson’s Covid-19 vaccine. The J&J vaccine is also currently being tested as a two-dose vaccine.
